$Verve Therapeutics (VERV.US)$ probably will run up after hours imo

$Femto Technologies (FMTO.US)$ $Baijiayun (RTC.US)$ $Verve Therapeutics (VERV.US)$ $EB ENVIRONMENT (00257.HK)$ $Gamehaus Holdings (GMHS.US)$ $USA Rare Earth (USAR.US)$ $Office Properties Income Trust (OPI.US)$ $Rail Vision (RVSN.US)$ $CISO Global (CISO.US)$ $Healthcare Triangle (HCTI.US)$ $NLS Pharmaceutics (NLSP.US)$ $ARB IOT Group (ARBB.US)$ $Splash Beverage (SBEV.US)$ $Synergy CHC (SNYR.US)$
📊⚡️📊

$Verve Therapeutics (VERV.US)$ Nice recovery

$Verve Therapeutics (VERV.US)$
Breakthrough: New Gene Editing Drug Cuts Bad Cholesterol by 53% in Heart Disease Patients

$Verve Therapeutics (VERV.US)$ what do you all think of this ? Almost oversold....

$Verve Therapeutics (VERV.US)$ Nice lil low volume climb

$Verve Therapeutics (VERV.US)$ Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102. The Heart-2 Phase 1b clinical trial is evaluating patients with heterozygous familial hypercholesterolemia (HeFH) and/or premature coronary artery disease (CAD), two populations that require deep and durable reductions of low-density lipoprotein choleste...